CSIMarket
 


Sigyn Therapeutics Inc   (RSAP)
Other Ticker:  
 

Sigyn Therapeutics Inc 's Working Capital Ratio

RSAP's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


In the wake of the increase in Current Liabilities in the forth quarter 2023, Working Capital Ratio fell to 0.03 a new company low.

Within Medical Equipment & Supplies industry 54 other companies have achieved higher Working Capital Ratio than Sigyn Therapeutics Inc in forth quarter 2023. While Working Capital Ratio total ranking has improved so far during the IV Quarter 2023 to 1475, from total ranking in the second quarter 2023 at 5005.

Explain Working Capital Ratio
How much in Current Assets RSAP´s has?
What is the value of RSAP´s Current Liabilities?


RSAP Working Capital Ratio (Dec 31 2023)
IV. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change 94.86 % 146.95 % 207.67 % 190 % 134 %
Y / Y Current Assets Change 38.28 % 22.67 % 187.19 % -82.11 % -92.35 %
Working Capital Ratio MRQ 0.03 0.04 0.15 0.04 0.05
RSAP's Total Ranking # 1475 # 5005 # 5419 # 5704 #
Seq. Current Liabilities Change 11.16 % 16.83 % 39.23 % 7.77 % 40.87 %
Seq. Current Assets Change -8.33 % -68.78 % 486.77 % -17.66 % -18.69 %



Working Capital Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 55
Healthcare Sector # 185
Overall Market # 1475


Working Capital Ratio Statistics
High Average Low
2.3 0.44 0.03
(Jun 30 2021)   (Dec 31 2023)




Financial Statements
Sigyn Therapeutics Inc 's Current Liabilities $ 4 Millions Visit RSAP's Balance sheet
Sigyn Therapeutics Inc 's Current Assets $ 0 Millions Visit RSAP's Balance sheet
Source of RSAP's Sales Visit RSAP's Sales by Geography


Cumulative Sigyn Therapeutics Inc 's Working Capital Ratio

RSAP's Working Capital Ratio for the trailling 12 Months

RSAP Working Capital Ratio

(Dec 31 2023)
IV. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 94.86 % 146.95 % 207.67 % 190 % 134 %
Y / Y Current Assets TTM Growth 38.28 % 22.67 % 187.19 % -82.11 % -92.35 %
Working Capital Ratio TTM 0.06 0.07 0.08 0.07 0.15
Total Ranking TTM # 2420 # 4099 # 4723 # 4843 #
Seq. Current Liabilities TTM Growth 11.16 % 16.83 % 39.23 % 7.77 % 40.87 %
Seq. Current Assets TTM Growth -8.33 % -68.78 % 486.77 % -17.66 % -18.69 %


On the trailing twelve months basis Due to increase in Current Liabilities in the IV Quarter 2023 to $3.61 millions, cumulative Working Capital Ratio decreased to 0.06 below the Sigyn Therapeutics Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 128 other companies have achieved higher Working Capital Ratio than Sigyn Therapeutics Inc . While Working Capital Ratio overall ranking has improved so far to 2420, from total ranking during the twelve months ending second quarter 2023 at 4099.

Explain Working Capital Ratio
How much in Current Assets RSAP´s has?
What is the value of RSAP´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 129
Healthcare Sector # 493
Within the Market # 2420


trailing twelve months Working Capital Ratio Statistics
High Average Low
1.41 0.32 0.06
(Sep 30 2021)   (Dec 31 2023)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Working Capital RatioDec 31 2023 MRQ Current AssetsDec 31 2023 MRQ Current Liabilities
Altair International Corp   0.06 $ 0.017  Millions$ 0.279  Millions
Odyssey Health Inc   0.05 $ 0.259  Millions$ 5.380  Millions
Sigyn Therapeutics Inc   0.03 $ 0.118  Millions$ 3.608  Millions
Qt Imaging Holdings Inc   0.01 $ 0.096  Millions$ 12.683  Millions

Date modified: 2024-02-21T12:11:37+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com